Litigation Details for BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)
✉ Email this page to a colleague
BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-12-06 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | |
| Patents | 6,559,158; 8,524,276 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH COMPANIES INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-07-17 | 187 | the 1970s. ’276 patent, col.1 ll.62- 3. U.S. Patent No. 6,559,158 (the “’158 patent”), filed in 2000…formulation. ’276 patent, col.2 ll.27-41. U.S. Patent No. 6,274,591 (the “’591 patent”) claimed a method…Actavis.”) Plaintiffs own U.S. Patent No. 8,524,276 (“the ’276 patent”), which is listed in the Orange…infringed the ’276 patent. A bench trial on both infringement and Actavis’ patent invalidity defenses… U.S. Patent Publication No. 2005/0004155 (“Boyd ’155”); U.S. Patent Publication | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
